Rosette Lidereau
Impact in
- Cancer Research top 0.1%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Oncology top 0.2%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
-
- Genomics and Chromatin Dynamics 24
- Oncology 91
- Cancer-related Molecular Pathways 42
- HER2/EGFR in Cancer Research 21
- Co-authors
- Ivan Bièche (138 shared papers)Robert Callahan (24 shared papers)Michel Vidaud (21 shared papers)Sengül Tozlu (19 shared papers)Sophie Vacher (34 shared papers)Keltouma Driouch (37 shared papers)Charles Theillet (9 shared papers)Igor Girault (13 shared papers)
- Journals
- International Journal of Cancer (18 papers)Genes Chromosomes and Cancer (11 papers)British Journal of Cancer (11 papers)Oncogene (10 papers)Cancer Research (7 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Rosette Lidereau
260 papers receiving 15.8k citations
Rosette Lidereau's Hit Papers
Peers
Comparison fields: 5 of 146
- Cancer Research 4.2k
- Oncology 5.3k
- Molecular Biology 8.2k
- Genetics 2.9k
- Pathology and Forensic Medicine 1.7k
Countries citing papers authored by Rosette Lidereau
This map shows the geographic impact of Rosette Lidereau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosette Lidereau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosette Lidereau more than expected).
Fields of papers citing papers by Rosette Lidereau
This network shows the impact of papers produced by Rosette Lidereau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosette Lidereau. The network helps show where Rosette Lidereau may publish in the future.
Co-authors
The 25 scholars most cited alongside Rosette Lidereau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 263 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer Hit paper breakdown → | 2006 | 845 |
| 2 | Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series Hit paper breakdown → | 2007 | 730 |
| 3 | 2007 | 461 | |
| 4 | 2006 | 441 | |
| 5 | 1986 | 345 | |
| 6 | 1987 | 288 | |
| 7 | Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. | 2003 | 285 |
| 8 | 2007 | 264 | |
| 9 | 1995 | 263 | |
| 10 | 1995 | 222 | |
| 11 | 2011 | 218 | |
| 12 | 1999 | 217 | |
| 13 | Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays. | 2001 | 208 |
| 14 | Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay. | 1999 | 206 |
| 15 | 1998 | 200 | |
| 16 | 1994 | 195 | |
| 17 | 1988 | 194 | |
| 18 | 2006 | 192 | |
| 19 | 2004 | 189 | |
| 20 | Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas. | 1986 | 187 |
About Rosette Lidereau
Rosette Lidereau is a scholar working on Molecular Biology, Oncology, Genetics, Cancer Research and Pathology and Forensic Medicine, having authored 263 papers that have together received 16.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (42 papers), Cancer Genomics and Diagnostics (35 papers), BRCA gene mutations in cancer (28 papers), Genetic factors in colorectal cancer (25 papers), Genomics and Chromatin Dynamics (24 papers), Genomic variations and chromosomal abnormalities (22 papers), HER2/EGFR in Cancer Research (21 papers) and Estrogen and related hormone effects (19 papers). The work is most often cited by research in Cancer Research (4.2k citations), Oncology (5.3k citations), Molecular Biology (8.2k citations), Genetics (2.9k citations) and Pathology and Forensic Medicine (1.7k citations). Rosette Lidereau has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Ivan Bièche, Robert Callahan, Michel Vidaud, Sengül Tozlu, Sophie Vacher, Keltouma Driouch, Charles Theillet, Igor Girault, M.H. Champème and Martine Olivi. Their work appears in journals such as International Journal of Cancer, Genes Chromosomes and Cancer, British Journal of Cancer, Oncogene and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.